Duke CTSI Multidisciplinary Vision Program (MVP) Award

Applications for this funding program are currently closed.

The Duke CTSI Multidisciplinary Vision Program (MVP) Award provides funding up to $110,000 per award to support novel clinical translational research focused on improving health and healthy equity. Award amounts vary based upon amount requested and budget evaluation by the Program Leadership Committee. Please note that the funding period is from 05/01/2022- 04/30/2023 and that funds must be expended by 04/30/2023. 

Duke CTSI supports clinical translational research endeavors under the following domains: 

  • Methods/Processes: Scientific study of, and innovation in, the individual steps of the translational process, and its integration into an efficient system of translation from discovery to community. 
  • Collaboration/Engagement: Research in the structures, rationales, operations, purposes, outcomes, and metrics of engagement with stakeholders at each step of the translational process to elucidate principles and practices that make translation maximally efficient, focused, and relevant. 
  • Informatics: Development, demonstration, and dissemination of informatics and Information Technology (IT) innovations that accelerate both the science and operations of clinical translation. 
  • Integration Across the Lifespan: Development of scientific insights, and operational processes that will ensure that translational advances are realized in all populations, including children, pregnant and lactating women, the elderly, and other special populations, with particular emphasis on life stage transitions. 
  • Workforce Development: Innovations in the substance and culture of translational science workforce development, to create and sustain a robust, supported workforce with the skills, knowledge, and institutional environment necessary for continuous improvement in translational research and science. 

Clinical and Translational research includes:

  • Studies that address mechanisms contributing to human health and health equity, regardless of whether the context of the discovery is the laboratory, individuals, or communities.
  • Studies that contribute to improvements in health or health equity by addressing barriers to clinical care or access to care in community or population settings.
  • Research that contributes to improved health outcomes or health equity through changes in clinical practice or health policy.

Proposals from teams of investigators from different disciplines are encouraged. Collaborations that bring together ideas, theories, methods and approaches from disparate scientific disciplines are particularly encouraged.

Key Dates

  • Letter of ‘Intent to Submit’ (Mandatory): Jan 13, 2022 
  • Application Submission Deadline: February 10, 2022 
  • Final Selection: March, 2022 
  • Project Planning Run-In Period: March, 2022 through April 30, 2022 
  • Funding Period: May 1, 2022 through April 30, 2023

View the full RFA and application instructions.